Edition:
United Kingdom

Genocea Biosciences Inc (GNCA.OQ)

GNCA.OQ on NASDAQ Stock Exchange Global Market

0.62USD
20 Aug 2018
Change (% chg)

$-0.02 (-3.16%)
Prev Close
$0.65
Open
$0.66
Day's High
$0.66
Day's Low
$0.62
Volume
7,934
Avg. Vol
139,997
52-wk High
$5.61
52-wk Low
$0.56

Latest Key Developments (Source: Significant Developments)

Genocea Biosciences Inc QTRLY Loss Per Share $0.05
Thursday, 2 Aug 2018 

Genocea Biosciences Inc ::GENOCEA REPORTS SECOND QUARTER 2018 FINANCIAL AND OPERATING RESULTS.GENOCEA BIOSCIENCES INC QTRLY LOSS PER SHARE $0.05.GENOCEA BIOSCIENCES - EXPECT EXISTING CASH & CASH EQUIVALENTS SUFFICIENT TO SUPPORT OPERATING EXPENSES & CAPEX NEEDS INTO Q4 2019.GENOCEA BIOSCIENCES INC - CONTINUES TO EXPLORE STRATEGIC ALTERNATIVES FOR GEN-003.  Full Article

Genocea Biosciences Files For Mixed Shelf Of Up To $200 Mln
Monday, 21 May 2018 

May 21 (Reuters) - Genocea Biosciences Inc ::GENOCEA BIOSCIENCES INC - FILES FOR MIXED SHELF OF UP TO $200 MILLION - SEC FILING.  Full Article

Genocea Biosciences Enters Into Term Loan Facility Of $14 Million With Hercules
Tuesday, 1 May 2018 

April 30 (Reuters) - Genocea Biosciences Inc ::GENOCEA BIOSCIENCES INC - ON APRIL 24, CO ENTERED INTO TERM LOAN FACILITY OF $14 MILLION WITH HERCULES.GENOCEA BIOSCIENCES INC - TERM LOAN WILL MATURE ON MAY 1, 2021.  Full Article

Genocea Files IND For Neoantigen Cancer Vaccine Candidate Gen-009
Monday, 30 Apr 2018 

April 30 (Reuters) - Genocea Biosciences Inc ::GENOCEA - FILES IND FOR NEOANTIGEN CANCER VACCINE CANDIDATE GEN-009, PLANS TO INITIATE PHASE 1/2A CLINICAL PROGRAM LATER THIS YEAR.GENOCEA - TOP-LINE IMMUNE RESPONSE DATA FROM STUDY EXPECTED IN THE FIRST HALF OF 2019.  Full Article

New Enterprise Associates 16 Reports A 39.7 Pct Stake In Genocea Biosciences As Of Jan 17
Friday, 26 Jan 2018 

Jan 26 (Reuters) - Genocea Biosciences Inc ::NEW ENTERPRISE ASSOCIATES 16, L.P. REPORTS A 39.7 PERCENT STAKE IN GENOCEA BIOSCIENCES INC AS OF JAN 17 - SEC FILING.  Full Article

Genocea Biosciences Announces Proposed Concurrent Public Offerings Of Common Stock
Tuesday, 16 Jan 2018 

Jan 16 (Reuters) - Genocea Biosciences Inc ::GENOCEA BIOSCIENCES, INC. ANNOUNCES PROPOSED CONCURRENT PUBLIC OFFERINGS OF COMMON STOCK AND CLASS A WARRANTS AND SERIES A CONVERTIBLE PREFERRED STOCK AND CLASS A WARRANTS.GENOCEA BIOSCIENCES INC - ‍GENOCEA INTENDS TO USE NET PROCEEDS FROM CONCURRENT OFFERINGS TO SUPPORT ONGOING DEVELOPMENT OF ITS GEN-009 PROGRAM​.  Full Article

Genocea Biosciences inc qtrly ‍loss per share $0.59​
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - Genocea Biosciences Inc :Genocea reports third quarter 2017 financial results.Genocea biosciences - ‍expects existing cash and cash equivalents sufficient to support operating expenses and capital expenditure into middle of 2018​.Genocea biosciences inc - ‍cash and cash equivalents as of september 30, 2017 were $22.0 million compared to $35.2 million as of june 30, 2017​.Genocea biosciences inc qtrly ‍loss per share $0.59​.Q3 earnings per share view $-0.53 -- Thomson Reuters I/B/E/S.  Full Article

BRIEF-Genocea Biosciences Files For Mixed Shelf Of Up To $200 Mln

* GENOCEA BIOSCIENCES INC - FILES FOR MIXED SHELF OF UP TO $200 MILLION - SEC FILING Source text: (https://bit.ly/2GBQyfr) Further company coverage: